- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01709552
Brief Intervention for Substance Use and Partner Abuse Among Females in the ER (B-SAFER)
May 21, 2015 updated by: Esther Choo, Rhode Island Hospital
A Computer-based Intervention for Women With Substance Use and Intimate Partner Violence in the Emergency Department
The purpose of this study is to target co-occurring problems of substance use and intimate partner violence (IPV) using a computer-based intervention, B-SAFER (Brief intervention for Substance use and partner Abuse for Females in the Emergency Room).
This project will develop and test the computer-based intervention, examining primary outcomes of substance use and utilization of relationship safety resources.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital Department of Emergency Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- ≥18 years of age
- English or Spanish language proficiency sufficient to understand and complete study procedures
- moderate drug use in the prior 3 months (by NM-ASSIST)
- IPV victimization in the prior 6 months (by WAST)
- access to a phone
Exclusion Criteria:
Patients who are:
- intoxicated
- medically unstable as determined by ED staff
- suicidal ideation
- psychosis
- combative
- in police custody
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Computer Intervention
Patients randomized to the computer intervention will complete the B-SAFER computer program during their emergency department visit.
|
Patients randomized to the computer intervention will complete the B-SAFER computer program during their emergency department visit.
|
Sham Comparator: Control
Patients randomized to the control arm will receive a time-equivalent computer-based program unrelated to substance use or partner violence.
|
Patients randomized to the control arm will receive a time-equivalent computer-based program unrelated to substance use or partner violence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in past-month drug use days
Time Frame: 1 month, 3 month
|
Drug use based on Timeline Followback.
|
1 month, 3 month
|
Change in use of relationship safety behaviors and referral resources for IPV.
Time Frame: 2 weeks, 1 month, 3 months
|
Based on Safety Behavior Checklist and Effectiveness in Obtaining Resources scales.
|
2 weeks, 1 month, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in readiness to change drug use.
Time Frame: 2 week, 1 month, 3 months
|
Based on readiness to change rulers.
|
2 week, 1 month, 3 months
|
Change in readiness to change scale for relationship safety behaviors.
Time Frame: 2 weeks, 1 month, 3 months
|
Based on readiness to change rulers.
|
2 weeks, 1 month, 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Esther K Choo, MD MPH, Rhode Island Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
August 10, 2012
First Submitted That Met QC Criteria
October 16, 2012
First Posted (Estimate)
October 18, 2012
Study Record Updates
Last Update Posted (Estimate)
May 22, 2015
Last Update Submitted That Met QC Criteria
May 21, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5K23DA031881-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Related Disorders
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentRecruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA)Completed
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
Clinical Trials on Computer Intervention
-
Wayne State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetesUnited States
-
University of California, San FranciscoAkili Interactive Labs, Inc.CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical Center; Tobacco Related Disease Research...Completed
-
Henry Ford Health SystemNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Enrolling by invitationBehavior, HealthUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related DisordersUnited States
-
The University of Hong KongChinese University of Hong Kong; The Hong Kong Polytechnic University; Hong Kong... and other collaboratorsCompleted
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related DisordersUnited States
-
University of Rhode IslandCompletedPrevention Harmful EffectsUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedHealth Status UnknownUnited States
-
Albert Einstein College of MedicineCompletedObesity | Overweight